OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Self-citationSaito, T., & Rehmsmeier, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118432 · Cited by 5,309
Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979 · cited 1×
“45 Meanwhile, OWL had a comparable discriminative power with PLCO m2012 model even among the PLCO population, and had a ef fi ciency similar to PLCO m2012 in the NLST population, which is composed of heavy smokers, indicating plausible generalizability and scalability of the proposed OWL model.”
MethodReduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624 · cited 1×
“5,6 Identifying suitable subpopulation at high risk of lung cancer for LDCT screening has become essential to maximize the cost-effectiveness of screening programs.”
BackgroundPROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
Wolff, R. F., Moons, K. G. M., Riley, R. D., Whiting, P. F., Westwood, M., Collins, G. S., Reitsma, J. B., Kleijnen, J., Mallett, S., & for the PROBAST Group† (2019) · Annals of Internal Medicine · doi:10.7326/m18-1376 · Cited by 2,984
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Vickers, A. J., Van Calster, B., & Steyerberg, E. W. (2016) · BMJ · doi:10.1136/bmj.i6 · Cited by 1,163
A guide to systematic review and meta-analysis of prediction model performance
Debray, T. P. A., Damen, J. A. A. G., Snell, K. I. E., Ensor, J., Hooft, L., Reitsma, J. B., Riley, R. D., & Moons, K. G. M. (2017) · BMJ · doi:10.1136/bmj.i6460 · Cited by 657 · cited 1×
“Model calibration was assessed by the ratio of the expected to the observed lung cancer cases (EO ratio), 29,38,39 and by plotting the mean predicted absolute risk against the mean observed lung cancer risk within each risk group (calibration curve).”
Method
Research works printed but not linked: 38
- Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209
- Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 · DOI · Paper page
- Moyer, 2014, Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 160, 330, 10.7326/M13-2771 · DOI · Paper page
- Field, 2016, The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer, Health Technol Assess, 20, 1, 10.3310/hta20400 · DOI · Paper page
- Oudkerk, 2017, European position statement on lung cancer screening, Lancet Oncol, 18, e754, 10.1016/S1470-2045(17)30861-6 · DOI · Paper page
- Oudkerk, 2021, Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives, Nat Rev Clin Oncol, 18, 135, 10.1038/s41571-020-00432-6 · DOI · Paper page
- Tammemägi, 2021, USPSTF2013 vs. PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study, Lancet Oncol, 23, 138, 10.1016/S1470-2045(21)00590-8 · DOI · Paper page
- Ten Haaf, 2020, A comparative modeling analysis of risk-based lung cancer screening strategies, J Natl Cancer Inst, 112, 466, 10.1093/jnci/djz164 · DOI
- Toumazis, 2020, Risk-based lung cancer screening: a systematic review, Lung Cancer, 147, 154, 10.1016/j.lungcan.2020.07.007 · DOI · Paper page
- Tammemägi, 2013, Selection criteria for lung-cancer screening, N Engl J Med, 368, 728, 10.1056/NEJMoa1211776 · DOI · Paper page
- Cassidy, 2008, The LLP risk model: an individual risk prediction model for lung cancer, Br J Cancer, 98, 270, 10.1038/sj.bjc.6604158 · DOI · Paper page
- Field, 2021, Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation, Thorax, 76, 161, 10.1136/thoraxjnl-2020-215158 · DOI
- Tammemägi, 2014, Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts, PLoS Med, 11, 10.1371/journal.pmed.1001764 · DOI · Paper page
- Mazzone, 2021, Screening for lung cancer: CHEST guideline and expert panel report, Chest, 160, e427, 10.1016/j.chest.2021.06.063 · DOI · Paper page
- Hong, 2022, A comparison of XGBoost, random forest, and nomograph for the prediction of disease severity in patients with COVID-19 pneumonia: implications of cytokine and immune cell profile, Front Cell Infect Microbiol, 12, 10.3389/fcimb.2022.819267 · DOI
- Lyu, 2020, The development and validation of risk prediction model for lung cancer: a systematic review, Zhonghua Yu Fang Yi Xue Za Zhi, 54, 430
- Horsfall, 2020, Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank, Thorax, 75, 955, 10.1136/thoraxjnl-2020-214756 · DOI
- Hung, 2021, Assessing lung cancer absolute risk trajectory based on a polygenic risk model, Cancer Res, 81, 1607, 10.1158/0008-5472.CAN-20-1237 · DOI
- Zhang, 2022, A large-scale genome-wide gene-gene interaction study of lung cancer susceptibility in Europeans with a trans-ethnic validation in asians, J Thorac Oncol, 17, 974, 10.1016/j.jtho.2022.04.011 · DOI
- Friedman, 2002, Stochastic gradient boosting, Comput Stat Data Anal, 38, 367, 10.1016/S0167-9473(01)00065-2 · DOI · Paper page
- Verwaeren, 2015, A search grid for parameter optimization as a byproduct of model sensitivity analysis, Appl Math Comput, 261, 8
- Katki, 2016, Development and validation of risk models to select ever-smokers for CT lung cancer screening, JAMA, 315, 2300, 10.1001/jama.2016.6255 · DOI · Paper page
- Rutter, 2003, Estimating the accuracy of psychological scales using longitudinal data, Biostatistics, 4, 97, 10.1093/biostatistics/4.1.97 · DOI
- Heagerty, 2000, Time-dependent ROC curves for censored survival data and a diagnostic marker, Biometrics, 56, 337, 10.1111/j.0006-341X.2000.00337.x · DOI · Paper page
- Abe, 2022, A prehospital triage system to detect traumatic intracranial hemorrhage using machine learning algorithms, JAMA Netw Open, 5, 10.1001/jamanetworkopen.2022.16393 · DOI
- He, 2009, Learning from imbalanced data, IEEE Trans Knowl Data Eng, 21, 1263, 10.1109/TKDE.2008.239 · DOI · Paper page
- Li, 2020, Deep learning on high-throughput transcriptomics to predict drug-induced liver injury, Front Bioeng Biotechnol, 8, 10.3389/fbioe.2020.562677 · DOI
- Wilcox, 2022, Chapter 5 - comparing two groups, 153
- Bandos, 2005, A permutation test sensitive to differences in areas for comparing ROC curves from a paired design, Stat Med, 24, 2873, 10.1002/sim.2149 · DOI · Paper page
- Robbins, 2021, Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom, Br J Cancer, 124, 2026, 10.1038/s41416-021-01278-0 · DOI
- Fitzgerald, 2015, Decision curve analysis, JAMA, 313, 409, 10.1001/jama.2015.37 · DOI · Paper page
- Van Calster, 2018, Reporting and interpreting decision curve analysis: a guide for investigators, Eur Urol, 74, 796, 10.1016/j.eururo.2018.08.038 · DOI · Paper page
- Balachandran, 2015, Nomograms in oncology: more than meets the eye, Lancet Oncol, 16, e173, 10.1016/S1470-2045(14)71116-7 · DOI · Paper page
- Katki, 2018, Implications of nine risk prediction models for selecting ever-smokers for computed tomography lung cancer screening, Ann Intern Med, 169, 10, 10.7326/M17-2701 · DOI · Paper page
- Ten Haaf, 2017, Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study, PLoS Med, 14, 10.1371/journal.pmed.1002277 · DOI · Paper page
- Faselis, 2022, Assessment of lung cancer risk among smokers for whom annual screening is not recommended, JAMA Oncol, 8, 1428, 10.1001/jamaoncol.2022.2952 · DOI
- Malhotra, 2016, Risk factors for lung cancer worldwide, Eur Respir J, 48, 889, 10.1183/13993003.00359-2016 · DOI · Paper page
- Chen, 2020, An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population, Chest, 157, 547, 10.1016/j.chest.2019.09.003 · DOI
Cited by
Cai, Y., Cai, Y.-Q., Tang, L.-Y., Wang, Y.-H., Gong, M., Jing, T.-C., Li, H.-J., Li-Ling, J., Hu, W., Yin, Z., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03273-7 · Cited by 122
Metadata
- Authors
- Pan, Z., Zhang, R., Shen, S., Lin, Y., Zhang, L., Wang, X., Ye, Q., Wang, X., Chen, J., Zhao, Y., Christiani, D. C., Li, Y., Chen, F., & Wei, Y.
- Venue
- eBioMedicine
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 88
- Pages
- 104443
- ISSN
- 2352-3964
- Cited by
- 43
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Institutes of Health (CA092824, CA209414, CA249096, CA269398, ES000002)
- National Natural Science Foundation of China (81973142, 82220108002, 82273737)
- National Institute of Health
- Nanjing Medical University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations. https://app.cochat.ai/papers/10.1016/j.ebiom.2023.104443
- The paper
- Pan, Z., Zhang, R., Shen, S., Lin, Y., Zhang, L., Wang, X., Ye, Q., Wang, X., Chen, J., Zhao, Y., Christiani, D. C., Li, Y., Chen, F., & Wei, Y. (2023). OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations. eBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104443
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.